X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmaceutical-technology.com/uncategorized/safinamide-mesylate-zambon-co-multiple-system-atrophy-msa-or-shy-drager-syndrome-or-multi-system-degeneration-likelihood-of-approval/#:~:text=Safinamide%20mesylate%20overview&text=It%20is%20under%20development%20for,syndrome%20and%20amyotrophic%20lateral%20sclerosis.
https://www.zambon.com/en/media/press/2023-07-18-zambon-presents-results-two-phase-3-promis-studies-cms-i-neb-patients-non
https://www.prnewswire.com/news-releases/zambon-announces-new-data-highlighting-lifetime-burden-of-illness-in-us-patients-with-bronchiolitis-obliterans-syndrome-at-ispor-2023-301817281.html
https://www.clinicaltrialsarena.com/news/zambon-enrolment-bos-therapy/
https://www.prnewswire.com/news-releases/zambon-completes-enrollment-in-phase-3-clinical-development-program-evaluating-liposomal-cyclosporine-a-for-inhalation-l-csa-i-in-patients-with-bronchiolitis-obliterans-syndrome-bos-301810878.html
https://pharmaceuticalmanufacturer.media/pharmaceutical-industry-insights/latest-pharmaceutical-manufacturing-industry-insights/zambon-and-ima-active-paving-the-way-towards-process-optimis/
https://www.prnewswire.com/news-releases/zambon-to-attend-the-chest-annual-meeting-2022-301649239.html
https://www.prnewswire.com/news-releases/zambon-announces-attendance-at-american-thoracic-society-ats-2022-annual-meeting-301545971.html
https://www.ouest-france.fr/pays-de-la-loire/avrille-49240/pres-d-angers-greve-chez-zach-system-a-avrille-l-usine-classee-seveso-7b48f9c6-9e2b-11ec-816b-ed6ee69963f0
https://www.biospace.com/article/releases/positive-results-from-phase-3-promis-i-study-of-cms-i-neb-in-patients-with-non-cystic-fibrosis-bronchiectasis-presented-at-european-respiratory-society-ers-annual-meeting/?s=71
Market Place
Share 
